March 29th 2023
The comparative safety and effectiveness of analgesic medications for acute non-specific low back pain are unclear, highlighting the need for higher quality randomized controlled trials comparing different medications.
Treatment Advancements to Overcome Barriers in the Management of Schizophrenia: Key Considerations for Pharmacists
1.5 Credit / Neurology, Psychiatry
View More
Effective Management of Moderate to Severe Pediatric Asthma: Applying Evidence-Based Case Reviews in Practice, featuring Patient Counseling Vignettes
1.5 Credits / Immunology, Respiratory
View More
Intravenous and Subcutaneous Immunoglobulin in the Management of Primary Immunodeficiency Disorders: Updates for Specialty Pharmacists
1.5 Credits / Immunology
View More
Comprehending Data From Integrated Continuous Glucose Monitoring Devices and Developing a Management Plan for Patients With Type 2 Diabetes (Pharmacy Technician Credit)
1.0 Credit / Endocrinology
View More
Comprehending Data From Integrated Continuous Glucose Monitoring Devices and Developing a Management Plan for Patients With Type 2 Diabetes (Pharmacist Credit)
1.0 Credit / Endocrinology
View More
Improving Clinical Outcomes for Anemia of Chronic Kidney Disease: A Focus on Novel Treatment Approaches (Pharmacy Technician Credit)
1.0 Credit / Hematology, Nephrology
View More
Improving Clinical Outcomes for Anemia of Chronic Kidney Disease: A Focus on Novel Treatment Approaches (Pharmacist Credit)
1.0 Credit / Hematology, Nephrology
View More
Optimizing Care for Patients With Endometrial Cancer: A Focus on Pharmacist Interventions and Mitigation of Health Equity Issues
1.0 Credit / Oncology, Women’s Health
View More
A Hidden Crisis: The Need for Treatments in Notalgia Paresthetica
March 28th 2023A silent disease characterized as a chronic cutaneous neuropathy, notalgia paresthetica has an unmet need yet to be fully understood and, dermatologists argue, an FDA-approved treatment could help improve understanding of the etiology and prevalence of this disease.
Guselkumab, Golimumab Combination Therapy More Effective for Ulcerative Colitis Than Either Alone
The results show 83% of patients in the combination group achieved clinical response at week 12, compared to 61% of the golimumab monotherapy group and 75% of the guselkumab group.
Subclinical, Asymptomatic Atherosclerosis Linked to 8-Fold Increase in Myocardial Infarction
March 28th 2023An analysis of more than 9000 adults aged 40 and older without known cardiovascular disease is shedding new light on the risk of myocardial infarction and mortality associated with subclinical coronary atherosclerosis.
Weight Regain May Not Completely Mitigate Benefits of Behavior Management Programs
March 28th 2023A systematic review and meta-analysis of more than 120 randomized trials offers new insight into the effects of weight regain on cardiometabolic risk up to 5 years after the cessation of a behavioral management program.
Revolo Readying Data on Allergen Sensitivity Drug
The treatment is a first-in-class peptide derived from mTB Chaperonin 60.1 that is often involved in resetting the immune system. The treatment is being evaluated in patients with eosinophilic esophagitis and allergen sensitivity.
Endocrine Case Report: Ear Pain in Diabetes
March 27th 2023Our latest endocrine case report from Brady Pregerson, MD, features a patient in their mid-70s with a history of diabetes mellitus and end-stage kidney disease presenting with 6 days of gradually worsening right ear pain. Can you determine the correct diagnosis?
Metformin Could Lower Osteoarthritis Risk in Type 2 Diabetes
March 26th 2023A retrospective analysis comparing propensity score matched metformin users against sulfonylurea users, results of the study indicate metformin use was associated with a 24% reduction in relative risk of developing osteoarthritis.
Investigators Identify Risk Factors for Drug-Induced Parkinsonism for Schizophrenia Patients
Various psychiatric symptoms, including more severe negative symptoms, lower cognition status, and lower excited symptoms were significantly linked to drug-induced parkinsonism induction.